Difference between revisions of "CT Volumetry Biomarker Ctte"

Revision as of 16:08, 13 April 2023

Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and Ritu Gill, MD, MPH

RSNA Staff Support: Julie Lisiecki

Meetings

Tcons are held periodically. Contact RSNA Staff for details.

Recent Call Summaries:

CT Volumetry BC Call Summaries Archive

Profile Development

Streamlined Profile (also on Profile page)

CT Tumor Volume Change for Advanced Disease (CTV-AD) 2022-07-21 Streamlined Profile

32 pages including Conformance Checklists

Status - Balloting Streamlined Profile

CT Tumor Volume Change Profile - Streamlined Draft 2022.03.03
CT Tumor Volume Change Profile - Streamlined Draft 2021.12.09

The Technically Confirmed Profile is on the Profiles page.

Stage 4 Planning

Draft Stage 4 Plan - Google Doc

Past and Future

Archived Versions of Profile-related documents.
Considerations for Future Editions of CTV-AD

Groundwork Projects

These projects investigate (and resolve) scientific questions underlying QIBA Profile work.

VolCT - Group 1A - Analyze Bias/Variance where Ground Truth is Known Deterministically
VolCT - Group 1B - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings
VolCT - Group 1C - Model Sources of Variability from a Systems Engineering Analysis
VolCT - Group 3A - Characterize variability due to algorithms (using phantoms / clinical data)
VolCT - Group 3B - Characterize clinical utility/efficacy with respect to clinical endpoints
VolCT - Colorado Group - Quantifying variability in measurement of pulmonary nodule

NIBIB-2 Proposal for CT Volumetry16-APR-2012

Reference Materials

2012

Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
- ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.
"Why QIBA?" - Specifics associated with CT device and software manufacturers.

2011

Dr Petrick's 2011 SPIE Presentation Materials
“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk
“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Paper
Compliance Documents: QIBA Approach to Compliance-- Andrew J. Buckler, MS, Program Director, QIBA 08.15.11

2010

Quantification in Imaging-Dr Dirk Colditz August 23, 2010
Project plan .jpg version as of 11-8-10

Reference Articles

Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. Academic Radiology
Radiology 2007 - Coronary Calcium Scoring - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses similar issues (e.g. achieving "standard" noise levels). It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. Academic Radiology
Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. Academic Radiology

Archive - Initial Target Selection and Roadmap

QIBA Funded Projects

Round 1

Round 2

Round 3

Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)

Round 4

Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)

Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)

Round 5

Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)

Round 6

Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)

@@ Line 1: / Line 1: @@
 {{TOCright}}
-:Co-chairs: Gregory Goldmacher, MD, PhD, MBA; Jenifer Siegelman, MD, MPH; Ehsan Samei, PhD
+:Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and Ritu Gill, MD, MPH
-:Secretary: Julie Lisiecki
+:RSNA Staff Support: Julie Lisiecki
-:[[Media:QIBA CT Volumetry Roster.pdf|'''Roster''']]
+* [http://tinyurl.com/QIBA-CT-Vol-Roster Roster]
+* [https://docs.google.com/spreadsheets/d/1qbBHaJNTAqHnAcmCTHsNfDph7hMyJ3NoUjYSdilVw8w/edit#gid=267283460 Attendance & Voting Privileges]
 ==Meetings==
-* Tcons are held roughly Weekly. Contact the secretary for details.
+* Tcons are held periodically. Contact RSNA Staff for details.
-* [[Call Summaries]]
-==Profile Development==
-===Advanced Disease/Tumor Volume Change Profile===
+'''Recent Call Summaries:'''
+*[[Media:03 21 2023 QIBA CT Volumetry BC Call-FINAL.pdf|03.21.2023 QIBA CT Volumetry BC Call Summary]]
+*[[Media:11 01 2022 QIBA CT Volumetry BC Call-FINAL.pdf|11.01.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:10 10 2022 QIBA CT Volumetry BC Call-FINAL.pdf|10.10.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:08 17 2022 QIBA CT Volumetry BC Call-FINAL.pdf|08.17.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:06 29 2022 QIBA CT Volumetry BC Call-FINAL.pdf|06.29.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:05 26 2022 QIBA CT Volumetry BC Call-FINAL.pdf|05.26.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:04 20 2022 QIBA CT Volumetry BC Call-FINAL.pdf|04.20.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:03 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|03.15.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:02 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|02.15.2022 QIBA CT Volumetry BC Call Summary]]
-'''Status - Consensus Profile complete'''
-*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf | QIBA Profile: CT Tumor Volume Change Profile]] ''CONSENSUS 2016.11.21b''
-:* [[Media:QIBA_CVol_TumorVolumeChangeChecklist-20161205_-_Field_Test_version_1.0.docx| Checklist - CT Tumor Volumetry for Advanced Disease]] ''Field Trial v1.0''
-'''Status - Technical Confirmation in progress'''
+'''''[[CT Volumetry BC Call Summaries Archive]]'''''
-*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_PostConsensus-20170403.docx | CT Tumor Volume Change Profile - PostConsensus]] ''DRAFT 2017.04.03''
-* '''[https://docs.google.com/spreadsheets/d/1cyz0frvELb6Tq1EHjpHxnvjeUxotExnJ3OrKPdIa30U/edit?usp=sharing Technical Confirmation Results and Resolutions]''' - ONGOING WORK
-:* Columbia Volume repeatability assessment - Coming Soon
-::* [[Media:QIBA_CT_Volumetry_Field_Test_ACR_Phantom_Scan_Protocol.pdf| Columbia Scan Protocol]]
-Past and Future
+==Profile Development==
-:* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
+'''Streamlined Profile (also on Profile page)'''
-:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
+* [[Media:QIBACTVol_TumorVolumeChange(2022)-20220721.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2022-07-21 Streamlined Profile]]
+:* 32 pages including Conformance Checklists
+'''Status - Balloting Streamlined Profile'''
+*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20220303.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2022.03.03
+*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20211209.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2021.12.09
-===<font color=green>Lung Nodule Assessment in CT Screening Profile</font>===
+The Technically Confirmed Profile is on the [[Profiles]] page.
-===<font color=red>''Status - Consensus in progress''</font>===
+'''Stage 4 Planning'''
+:* [https://docs.google.com/document/d/1Wcmkzp8N_2lLL-FCykNPwgsn1BJOs7Z9A1ZyTIkuGCo/edit?usp=sharing Draft Stage 4 Plan - Google Doc]
-* [[Media:2017-10-07 Final QIBASmallNoduleProfileTF CommentResponse.pdf|QIBA Lung Nodule Profile Comment Response]] ''2017.10.07''
+'''Past and Future'''
-* [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_2017.09.27.docx|QIBA Lung Nodule Profile]] ''Draft 2017.09.27''
+:* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
+:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
-''Supporting documents:''
-* [[Media:#10333_ Avila et al. Automatic Estimation of Measurement Error on CT Imaging.pdf|#10333_ Avila et al. Automatic Estimation of Measurement Error on CT Imaging]]
-* [[Media:#10341_Avila et al. A Novel Ultra Low Cost CT Image Quality Measurement Dev.pdf|#10341_Avila et al. A Novel Ultra Low Cost CT Image Quality Measurement Dev]]
-* [[Media:2016-01-22 Avila WCTI-HotTopicAbstract v5.pdf|2016-01-22 Avila WCTI-HotTopicAbstract v5]]
-* [[Media:2016-07-21 AvilaIWCLCTapeQAAbstract.pdf|2016-07-21 AvilaIWCLCTapeQAAbstract]]
-* [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_2017.07.rev15.pdf|QIBA Lung Nodule Profile]] ''Draft 2017.08.02''
-:* [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_2017.05.15+KOD.docx|Comments on mid-May draft from Kevin]] ''2017.06.06''
-'''Status - Public Comment complete'''
-* [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx|QIBA Profile: CT Lung Nodule Assessment in Screening]] ''Public Comment 2016.06.01 (ended Sept 2016)''
-:* [[Media:QIBA Small Nodule Profile References - Accuracy.xlsx|Spreadsheet: Small Nodule Profile References_Accuracy]]
-:* [[Media:QIBA Small Nodule Profile References - Precision.xlsx|Spreadsheet: Small Nodule Profile References_Precision]]
-Past
-:*[[Archive for Lung Nodule Assessment in CT Screening Draft Profiles|Archived Versions]] of Profile-related documents.
 ==Groundwork Projects==
@@ Line 70: / Line 58: @@
 *Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 **[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
-*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
+*[[Media:Why QIBA CT specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
 '''2011'''
@@ Line 80: / Line 68: @@
 '''2010'''
 *[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
-*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
+*[[Media:Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
 ==Reference Articles==
@@ Line 102: / Line 90: @@
 *[[CoreLab Partners, Inc., Round-2]]
 *[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
+'''Round 3'''
+*[[Media:Second 3A Statistical and Image Processing Analysis.pdf| Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)]]
+'''Round 4'''
+*[[Media:Methodology and Reference Image Set for Volumetric Characterization and Compliance.pdf| Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)]]
+*[[Media:Phantoms for CT Volumetry of Hepatic and Nodal Metastasis.pdf| Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)]]
+'''Round 5'''
+*[[Media:Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization.pdf| Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)]]
+'''Round 6'''
+*[[Media:Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology.pdf| Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)]]